Clinical Trial Update: Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of pioglitazone on body composition, insulin sensitivity, and protein metabolism in patients with end-stage renal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: ESRD | Phase 4 | Status: UNKNOWN